|
MD Anderson residual cancer burden class of excised primary malignant neoplasm of breast after neoadjuvant therapy (observable entity)
MD Anderson residual cancer burden class of excised primary malignant neoplasm of breast after neoadjuvant therapy
Residual cancer burden class of post-neoadjuvant breast neoplasms is based on the summative residual cancer burden score and subsequent stratification of residual cancer levels.
Id1407204008
StatusPrimitive